Is STAAR Surgical Company (STAA) overvalued? · rev $313.9M
STAAR Surgical Company (STAA) is a medical instruments & supplies company listed on NASDAQ.
This page asks whether STAAR Surgical Company (STAA) looks expensive on cached numbers — not a short thesis.
Latest reported STAA revenue for 2024-12-27 was $313.9M. Net income was -$20.2M. Revenue was down 2.6% from 2023-12-29 to 2024-12-27. STAA currently screens at market cap $1.45B.
STAA currently screens at market cap $1.45B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next STAA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the STAA stock page for the full model, not this heading.
Not investment advice.